Skip to main content
Signal8
FALK THOMAS J profile photo

Thomas J. Falk

CIK: 0001222890

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AbbVie Inc. logo
ABBV

AbbVie Inc.

Director
LOCKHEED MARTIN CORP logo
LMT

LOCKHEED MARTIN CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • AbbVie Inc. logo
    ABBV

    AbbVie Inc.

    May 8, 2026
    Award(A)
    Direct
    1.1K shares-
  • LOCKHEED MARTIN CORP logo
    LMT

    LOCKHEED MARTIN CORP

    Feb 13, 2026
    Award(A)

    Phantom Stock Units

    Indirect
    261 shares-
  • AbbVie Inc. logo
    ABBV

    AbbVie Inc.

    May 9, 2025
    Award(A)
    Direct
    1.2K shares-
  • LOCKHEED MARTIN CORP logo
    LMT

    LOCKHEED MARTIN CORP

    Feb 14, 2025
    Award(A)

    Phantom Stock Units

    Indirect
    402 shares-

1-4 of 4

About FALK THOMAS J

FALK THOMAS J (SEC CIK 0001222890) files insider reports with the SEC as Director of AbbVie Inc. (ABBV) and Director of LOCKHEED MARTIN CORP (LMT).

Signal8 holds 5 ownership filings by FALK THOMAS J (1 Form 3, 4 Form 4), filed between Feb 19, 2025 and May 12, 2026. Those filings report 4 transactions, from Feb 14, 2025 to May 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FALK THOMAS J's filings is in BETHESDA, MD.

Recent filings by FALK THOMAS J

  • May 8, 2026: Grant or award of ABBV shares (Form 4, code A).
  • Feb 13, 2026: Grant or award of LMT derivative securities (Form 4, code A).
  • May 9, 2025: Grant or award of ABBV shares (Form 4, code A).
  • Feb 14, 2025: Grant or award of LMT derivative securities (Form 4, code A).

Other insiders filing for AbbVie Inc. (ABBV)

How to read Form 4 transaction codes